The mitochondrial genome in human adaptive radiation and disease: On the road to therapeutics and performance enhancement

Argov, 1986, Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study, Ann. Neurol., 19, 598, 10.1002/ana.410190615 Bai, 2001, Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene, J. Biol. Chem., 276, 38808, 10.1074/jbc.M106363200 Ballinger, 1992, Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion, Nat. Genet., 1, 11, 10.1038/ng0492-11 Ballinger, 1994, Mitochondrial diabetes revisited, Nat. Genet., 7, 458, 10.1038/ng0894-458 Bowmaker, 2003, Mammalian mitochondrial DNA replicates bidirectionally from an initiation zone, J. Biol. Chem., 278, 50961, 10.1074/jbc.M308028200 Clayton, 1982, Replication of animal mitochondrial DNA, Cell, 28, 693, 10.1016/0092-8674(82)90049-6 Coskun, 2003, Control region mtDNA variants: longevity, climatic adaptation and a forensic conundrum, Proc. Natl. Acad. Sci. U. S. A., 100, 2174, 10.1073/pnas.0630589100 Coskun, 2004, Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication, Proc. Natl. Acad. Sci. U. S. A., 101, 10726, 10.1073/pnas.0403649101 Delettre, 2000, Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy, Nat. Genet., 26, 207, 10.1038/79936 DiMauro, 2004, Mitochondrial medicine, Biochim. Biophys. Acta, 1659, 107, 10.1016/j.bbabio.2004.08.003 Eleff, 1984, 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle, Proc. Natl. Acad. Sci. U. S. A., 81, 3529, 10.1073/pnas.81.11.3529 Filipovska, 2004, Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation, FEBS Lett., 556, 180, 10.1016/S0014-5793(03)01403-0 Flierl, 2003, Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid, Mol. Ther., 7, 550, 10.1016/S1525-0016(03)00037-6 Flierl, 2005, Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse, Gene Ther., 12, 570, 10.1038/sj.gt.3302443 Geromel, 2001, Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes, Antisense Nucleic Acid Drug Dev., 11, 175, 10.1089/108729001300338708 Geromel, 2002, Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits, Mol. Genet. Metab., 77, 21, 10.1016/S1096-7192(02)00145-2 Guy, 2002, Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy, Ann. Neurol., 52, 534, 10.1002/ana.10354 Holt, 2003, Response: the mitochondrial DNA replication bubble has not burst, Trends Biochem. Sci., 28, 355, 10.1016/S0968-0004(03)00133-6 Holt, 1990, A new mitochondrial disease associated with mitochondrial DNA heteroplasmy, Am. J. Hum. Genet., 46, 428 James, 2004, Antioxidant and prooxidant properties of mitochondrial Coenzyme Q, Arch. Biochem. Biophys., 423, 47, 10.1016/j.abb.2003.12.025 Jauslin, 2003, Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants, FASEB J., 17, 1972, 10.1096/fj.03-0240fje Kaukonen, 2000, A. Role of adenine nucleotide translocator 1 in mtDNA maintenance, Science, 289, 782, 10.1126/science.289.5480.782 King, 1989, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science, 246, 500, 10.1126/science.2814477 Mandel, 2001, The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA, Nat. Genet., 29, 337, 10.1038/ng746 Manfredi, 2002, Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus, Nat. Genet., 30, 394, 10.1038/ng851 Melov, 1998, A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase, Nat. Genet., 18, 159, 10.1038/ng0298-159 Melov, 2000, Extension of life-span with superoxide dismutase/catalase mimetics, Science, 289, 1567, 10.1126/science.289.5484.1567 Melov, 2001, Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase–catalase mimetics, J. Neurosci., 21, 8348, 10.1523/JNEUROSCI.21-21-08348.2001 Michikawa, 1999, Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication, Science, 286, 774, 10.1126/science.286.5440.774 Mishmar, 2003, Natural selection shaped regional mtDNA variation in humans, Proc. Natl. Acad. Sci. U. S. A., 100, 171, 10.1073/pnas.0136972100 Naviaux, 2000, Options and challenges in the treatment of mitochondrial disease, Genet. Med., 2, 56, 10.1097/00125817-200001000-00040 Nishino, 1999, Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder, Science, 283, 689, 10.1126/science.283.5402.689 Petros, 2005, mtDNA mutations increase tumorigenicity in prostate cancer, Proc. Natl. Acad. Sci. U. S. A., 102, 719, 10.1073/pnas.0408894102 Procaccio, 2004, Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations, Neurology, 62, 1899, 10.1212/01.WNL.0000125251.56131.65 Qi, 2003, Optic neuropathy induced by reductions in mitochondrial superoxide dismutase, Invest. Ophthalmol. Vis. Sci., 44, 1088, 10.1167/iovs.02-0864 Qi, 2003, Suppression of complex I gene expression induces optic neuropathy, Ann. Neurol., 53, 198, 10.1002/ana.10426 Qi, 2004, SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I, Ann. Neurol., 56, 182, 10.1002/ana.20175 Ruiz-Pesini, 2004, Effects of purifying and adaptive selection on regional variation in human mtDNA, Science, 303, 223, 10.1126/science.1088434 Saada, 2001, Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy, Nat. Genet., 29, 342, 10.1038/ng751 Seo, 1998, Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells, Proc. Natl. Acad. Sci. U. S. A., 95, 9167, 10.1073/pnas.95.16.9167 Seo, 2000, Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells, J. Biol. Chem., 275, 37774, 10.1074/jbc.M007033200 Seo, 2002, A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition, Mol. Ther., 6, 336, 10.1006/mthe.2002.0674 Seo, 2004, Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiencies, Hum. Gene Ther., 15, 887, 10.1089/1043034041839217 Shoffner, 1994, Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment, Annu. Rev. Nutr., 14, 535, 10.1146/annurev.nu.14.070194.002535 Shoffner, 1989, Spontaneous Kearns–Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy, Proc. Natl. Acad. Sci. U. S. A., 86, 7952, 10.1073/pnas.86.20.7952 Smeitink, 1999, Protein Biosynthesis ′99. Human mitochondrial complex I in health and disease, Am. J. Hum. Genet., 64, 1505, 10.1086/302432 Smith, 2003, Delivery of bioactive molecules to mitochondria in vivo, Proc. Natl. Acad. Sci. U. S. A., 100, 5407, 10.1073/pnas.0931245100 Spelbrink, 2001, Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria, Nat. Genet., 28, 223, 10.1038/90058 Taylor, 1997, Treatment of mitochondrial disease, J. Bioenerg. Biomembranes, 29, 195, 10.1023/A:1022646215643 Taylor, 1997, Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids, Nat. Genet., 15, 212, 10.1038/ng0297-212 Tiranti, 1998, Mutations of SURF-1 in Leigh Disease associated with cytochrome c oxidase deficiency, Am. J. Hum. Genet., 63, 1609, 10.1086/302150 Trounce, 1996, Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells, Somat. Cell Mol. Genet., 22, 81, 10.1007/BF02374379 Trounce, 1994, Cytoplasmic transfer of the mtDNA nt 8993 T→G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio, Proc. Natl. Acad. Sci. U. S. A., 91, 8334, 10.1073/pnas.91.18.8334 Van Goethem, 2001, Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions, Nat. Genet., 28, 211, 10.1038/90034 Van Goethem, 2003, Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification, Neuromolecular Med., 3, 129, 10.1385/NMM:3:3:129 Wallace, 1987, Maternal genes: mitochondrial diseases, vol. 23, 137 Wallace, 2002, Mitochondrial genes in degenerative diseases, cancer and aging, 299 Wallace, 1988, Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy, Science, 242, 1427, 10.1126/science.3201231 Wallace, 1999, Mitochondrial DNA variation in human evolution and disease, Gene, 238, 211, 10.1016/S0378-1119(99)00295-4 Wallace, 2001, Mitochondria and neuro-ophthalmological diseases, vol. II, 2425 Zhu, 1998, SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome, Nat. Genet., 20, 337, 10.1038/3804 Zuchner, 2004, Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot–Marie–Tooth neuropathy type 2A, Nat. Genet., 36, 449, 10.1038/ng1341